AstraZeneca PLC (AZN) Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Group PLC (CATG) Into MedImmune, Inc.
10/29/2007 7:35:03 AM
More...
|
Biotech Firm Cambridge Antibody Technology Group PLC (CATG) Sheds Jobs as Owner AstraZeneca PLC (AZN) Submits it to Merger
10/22/2007 12:11:59 AM
More...
|
Dyax Corp. (DYAX) Licenses Antibody Phage Display Libraries to Cambridge Antibody Technology Group PLC (CATG)
8/2/2007 11:50:12 AM
More...
|
Antitope Announces Composite Protein Research Agreement with Cambridge Antibody Technology Group PLC (CATG)
4/24/2007 4:00:50 PM
More...
|
Cambridge Antibody Technology Group PLC (CATG) Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCo Therapeutics Inc.
1/8/2007 2:28:32 PM
More...
|
Cambridge Antibody Technology Group PLC (CATG) Announces Senior Management Promotions
12/8/2006 10:53:19 AM
More...
|
Cambridge Antibody Technology Group PLC (CATG) To Expand Operations In Cambridge, UK; To Create Over 200 Jobs
11/7/2006 9:18:38 AM
More...
|
Royalty Pharma AG Announces Agreement Regarding The Purchase Of The Rights To A Pre-Existing Royalty Interest In HUMIRA(R) From AstraZeneca PLC (AZN) And Cambridge Antibody Technology Group PLC (CATG)
10/26/2006 11:18:27 AM
More...
|
Cambridge Antibody Technology Group PLC (CATG) And MSM Protein Technologies Enter Drug Discovery Collaboration In The Field Of Multi-Spanning Membrane Proteins
10/17/2006 10:54:20 AM
More...
|
Cambridge Antibody Technology Group PLC (CATG) And Debiopharm S.A. Enter Into An Exclusive Agreement To Develop And Market SC-1 For Gastric Carcinomas
10/16/2006 10:58:31 AM
More...
|
|